Rapid Micro Biosystems (RPID) Capital Expenditures Growth (1y) (2021 - 2026)
Rapid Micro Biosystems (RPID) Capital Expenditures Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -6.72% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 15.89% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -47.73% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -11.95% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -43.42% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 27.22% |
| 10 | Rapid Micro Biosystems | 77.24 Mn | 54.29 Mn | 371,000.00 | 23.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.51% |
| Dec 31, 2025 | -41.21% |
| Sep 30, 2025 | 98.92% |
| Jun 30, 2025 | -153.16% |
| Mar 31, 2025 | -45.47% |
| Dec 31, 2024 | 459.41% |
| Sep 30, 2024 | -31.95% |
| Jun 30, 2024 | -44.02% |
| Mar 31, 2024 | 279.87% |
| Dec 31, 2023 | 104.45% |
| Sep 30, 2023 | -113.88% |
| Jun 30, 2023 | 173.02% |
| Mar 31, 2023 | -89.75% |
| Dec 31, 2022 | -860.34% |
| Sep 30, 2022 | 386.33% |
| Jun 30, 2022 | -696.45% |
| Mar 31, 2022 | 498.80% |
| Dec 31, 2021 | 469.35% |
| Sep 30, 2021 | 144.33% |